Polyclonal B‐cell activation in periodontitis*
- 1 July 1989
- journal article
- review article
- Published by Wiley in Journal of Periodontal Research
- Vol. 24 (4), 225-241
- https://doi.org/10.1111/j.1600-0765.1989.tb01787.x
Abstract
The evidence that periodontitis-associated bacteria contain potent PBA factors is very strong. Clearly, antibodies directed against non-oral antigens are produced in the inflamed periodontal lesion, and PBA appears to contribute to that production. It is also clear that B cells and plasma cells are the major cell types in the periodontal lesion. Furthermore, alterations in the regulation of B-cell responses to PBA factors are associated with severe periodontal disease. However, evidence demonstrating that activated B cells and plasma cells are directly involved in the pathogenic mechanisms leading to destruction of the periodontal support is still circumstantial. Polyclonal B-cell activation and potential pathways by which PBA-stimulated cells could be involved in periodontal destruction remain largely hypothetical. It appears that IL-1 is an important osteoclast-activating agent, and that LPS, which is a potent PBA factor in many systems, can elicit IL-1 production by B cells as well as by the monocyte/macrophage lineage. Recent data indicating that IL-1 is produced by numerous malignant B-cell lines lend support for the idea that B-cell IL-1 could be important in bone resorption. It is also likely that polyclonal activation may lead to production of autoantibody such as anti-type I and anti-type III collagens, and the destruction of self tissues through ADCC reactions, immune complex formation, and complement activation. Further research is needed to determine how the B cell/plasma cell may participate in tissue injury in periodontitis, and how the B-cell response to PBA factors is regulated.Keywords
This publication has 185 references indexed in Scilit:
- Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma CellsNew England Journal of Medicine, 1987
- Nocardia Water Soluble Mitogen (NWSM), a human B-lymphocyte mitogenInternational Journal of Immunopharmacology, 1986
- Amplification of the immune response by agonistic antibodiesImmunology Today, 1986
- Effect of a interleukin-I like factor (mononuclear cell factor) on proteoglycan synthesis in cultured human articular chondrocytesBiochemical and Biophysical Research Communications, 1986
- Immunoregulation in severe generalized periodontitisClinical Immunology and Immunopathology, 1985
- Cell-cycle control in lymphocyte stimulationImmunology Today, 1984
- Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1983
- EBV and rheumatoid arthritisImmunology Today, 1982
- B lymphocyte activationImmunology Today, 1981
- Lymphocyte-fibroblast interaction in the pathogenesis of inflammatory gingival diseaseCellular and Molecular Life Sciences, 1972